The Biological Action of Glass Wool

Our plain-English summary of The Biological Action of Glass Wool, by G.W.H. Schepers (1955).

The study

• Author: G.W.H. Schepers
• Published: Archives of Industrial Health, Volume 12. September 1955. Recorded for Publication July 11, 1955
• Type of article: Journal article
• Our copy: from Johns-Manville's own medical library. The article is still under copyright, so we describe it here rather than post it.

In plain English

This was an animal experiment in guinea pigs on glass wool, which the author compared with asbestos. One group received a single injection into the windpipe (intratracheal) of long-fiber, medium-caliber fibers labeled 20 to 50 microns. Another group inhaled short fibers under 6 microns. The article does not give animal numbers or doses. After injection, the lungs showed early cell reactions with giant cells containing glass. Much of this had receded by two months. Glass persisted at 12 months; by 18 months, widened, distorted airways were the main abnormality. In the inhalation group, little reaction appeared before the fourth month. By one year there was bronchitis, airway widening and focal pneumonitis. No "glass-wool bodies" like asbestos bodies were seen. The author concluded that glass is not fibrogenic (scar-forming) in the lung, but that glass wool should be regarded as potentially harmful where large quantities of the type of product studied are inhaled. The author noted that other glass wool may differ, and that the significance for cancer development of the airway lining overgrowth (epithelial hyperplasia) seen needs clarification.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: animal experiment (intratracheal injection study and inhalation study, examined by lung tissue pathology over time)
• Who was studied: guinea pigs; number of animals not stated; lungs examined at intervals up to 18 months
• Exposure: glass wool (not asbestos): long-fiber, medium-caliber fibers labeled 20 to 50 microns given by single intratracheal injection, and short-fiber, medium-caliber fibers under 6 microns given by inhalation; doses not stated
• Main results:
  • Intratracheal group, one month: alveoli contained many multinucleated giant cells holding glass fibers
  • Intratracheal group, two months: much of the first-month reaction had receded
  • Intratracheal group, 12 months: a considerable amount of glass was still present in the lung
  • Intratracheal group, 18 months: airways were distended, with crypts and papillae; this was more marked with the shorter, narrower fibers
  • Inhalation group: very little reaction before the fourth month
  • Inhalation group, one year: bronchitis and bronchiectasis with marked focal cellular pneumonitis
  • Some glass wool reached the hilar lymph nodes without causing local fibrosis
  • No glass-wool bodies comparable to asbestos bodies were seen
  • The author found that glass was not fibrogenic when retained in lung tissue
• The authors' conclusion: The author concluded that glass is not fibrogenic in the lung, but that glass wool should be regarded as a potentially harmful substance where large quantities of the type of product studied are inhaled
• Limitations the authors state:
  • The findings apply to the product studied; other modern glass wool or fiber glass may not have comparable effects
  • The significance of the bronchial epithelial hyperplasia seen in the animals for cancer development needs further clarification

Topics

Medical terms in this study, explained in our Lexicon: Pneumonitis, Asbestos Bodies, Fibrogenic.

Browse return to medical research.